While our current study revealed significant associations between MAGI2-AS3 expression and clinicopathological features such as tumor size, TNM stage, and histological grade, we acknowledge that the limited sample size constrained our ability to comprehensively evaluate its diagnostic accuracy across all breast cancer subtypes. This evidence concerns the gene MAGI2 and breast cancer.